Sponsored by:

Nuclear Medicine: Page 210

Sofie to receive patent for PET probes
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has been told that it will receive a U.S. patent that covers a line of novel PET probes, known as F-18 FAC.
January 23, 2012
NRG gets OK for new nuclear reactor
By AuntMinnie.com staff writers
Radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) received approval from the Dutch government on January 20 to proceed with a new nuclear research reactor to replace an existing reactor in Petten.
January 22, 2012
ASCO: PET, PET/CT show broad utility in gastrointestinal cancer
By Eric Barnes
SAN FRANCISCO - FDG-PET and PET/CT are critical imaging modalities in diagnosing and managing patients with gastrointestinal cancer, as demonstrated in several lines of research presented at this week's American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium.
January 19, 2012
Almeida named Covidien chairman
By AuntMinnie.com staff writers
Healthcare technology firm Covidien's board of directors has added chairman to President and CEO José Almeida's responsibilities, effective March 13.
January 19, 2012
Navidea touts Alzheimer's study results
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals is touting clinical results from a study that included the use of its late-stage radiopharmaceutical imaging candidate, AZD4694, for detecting cerebral amyloid in Alzheimer's disease patients.
January 19, 2012
GE touts flutemetamol study results
By AuntMinnie.com staff writers
GE Healthcare is touting the results of two studies that suggest the company's investigational imaging agent F-18 flutemetamol could combine with other diagnostic tools to evaluate neurodegenerative conditions such as Alzheimer's disease.
January 16, 2012
Positron acquires Manhattan Isotope
By AuntMinnie.com staff writers
Molecular imaging developer Positron has completed its acquisition of Manhattan Isotope Technology.
January 16, 2012
FDA: User error caused CardioGen-82 mishaps
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has confirmed that the "improper usage" of Bracco Diagnostics' CardioGen-82 cardiac PET radiopharmaceutical caused three patients from two different facilities to have increased levels of radiation in their bodies following PET scans.
January 16, 2012
Noninvasive imaging drives cardiac growth
By AuntMinnie.com staff writers
Cardiologists have substantially increased their billing for services over the past decade, but nearly all of the growth has been in noninvasive procedures, such as noninvasive imaging using CT, MRI, and ultrasound, according to a study published online January 10 in Circulation: Cardiovascular Quality and Outcomes.
January 15, 2012
Bayer's Trudeau to lead Covidien pharma unit
By AuntMinnie.com staff writers
Healthcare technology firm Covidien has appointed Mark Trudeau as president of its pharmaceuticals segment and a senior vice president of the company, effective February 1.
January 15, 2012
BSGI helps detect more breast cancer, alter treatment
By Wayne Forrest
Breast-specific gamma imaging (BSGI) confirmed mammography, ultrasound, and MRI results in 55% of patients and identified additional malignant lesions, clarified ambiguous findings, or significantly changed patient management in 20% of cases, according to a study from California researchers.
January 12, 2012
2012 01 12 16 58 11 726 Ll Brs Tu5 B Bsgi Thumb
Carestream earns 47 U.S. patents in 2011
By AuntMinnie.com staff writers
Carestream Health and its subsidiaries received 47 patents in 2011 from the U.S. Patent and Trademark Office for innovations in its radiology imaging and healthcare IT, dental imaging, and molecular imaging offerings.
January 11, 2012
Previous Page
Page 210 of 440
Next Page